Deutsche Bank Aktiengesellschaft »

Sab Biotherapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2026-06-30 $165k 42k 3.90